Skip to main content
Request a Sample

CoQ10 Delivery Formats

Compare three CoQ10 delivery formats across the NexaGens platforms: liposomal powder, microencapsulated powder and protected immediate-release pellets. Request current technical data before evaluation.

CoQ10 Delivery Formats — 3 ingredients

Showing 3 of 3 ingredients
No image Stability-Protected Functional Pellet

PelleTune™ Coenzyme Q10 Protected IR Pellets 40% w/w

Single-active stability-protected ir pellet designed for oxidation, light and heat sens...

No image Microencapsulated Powder

Kapsyra™ Microencapsulated Coenzyme Q10

Single-active microencapsulated powder designed for oxidation, light exposure, dispersi...

Liposomal CoQ10 powder 25–30% technical overview Liposomal Powder

Vezicle™ Liposomal Coenzyme Q10 Powder 25–30%

Single-active liposomal powder designed for very low water solubility, wetting, dispers...

Technical selection guide

How to compare NexaGens coenzyme Q10 delivery formats

NexaGens offers coenzyme Q10 as a liposomal powder, microencapsulated powder and protected immediate-release pellet. These formats address different formulation requirements and should not be selected on active name alone.

What differs between the three CoQ10 formats?

The formats differ in active loading, carrier or coating system, physical form, handling characteristics and the evidence supporting their technical positioning.

All three are product-specific formulation modules. Review the current specification for the exact loading, release behaviour and physical parameters before comparing commercial suitability.

Which formulation objective should guide the choice?

Choose according to the required dispersion, stability protection, powder handling and compatibility with the intended dosage form.

A protected immediate-release pellet is not a sustained-release product. Likewise, liposomal or microencapsulated terminology should not be interpreted as a human-bioavailability claim.

What evidence should buyers compare?

Compare technical data sheets, finished-product specifications, batch CoAs, stability evidence and platform-specific characterisation or performance data.

Evaluate each format in the complete formulation and confirm regulatory suitability, processing compatibility and commercial pack requirements.

Discuss your formulation requirement

Tell us the active, dosage form, target market, processing conditions, target release or protection profile and expected volume. We can help identify suitable evaluation materials and confirm the available technical documents.